Search
for
Sort by
Research 391–420 of 447
- Mechanotransduction in Androgenetic Alopecia: An In Silico Repositioning Study of PIEZO1 + MLCK Axis Using Cofolding and Pilosebaceous Single-Cell Atlas Constraints
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- PC-SPES Studies Promising, But Manufacturer Shuts Down
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- OA08 Ocrelizumab in pregnancy in a patient with juvenile onset systemic lupus erythematosus
- Alopecia androgénica en una paciente con lupus eritematoso sistémico
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Vitiligo and alopecia areata: apples and oranges?
- Extra-Intestinal Manifestation of Celiac Disease in Children
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- New developments in the treatment of systemic lupus erythematosus
- Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Oral Lichen Planus
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Advanced 3D/4D Bioprinting of Flexible Conductive Materials for Regenerative Medicine: From Bioinspired Design to Intelligent Regeneration
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- Disease-related biomarkers as experimental endpoints in 3D skin culture models
- Alopecia areata: medical treatments
- Real-World Outcomes and Healthcare Utilization of Lanadelumab in Spain: Insights from First Cohort of Difficult-to-Treat Hereditary Angioedema Cases
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review